Novo Integrated Sciences Inc (NASDAQ:NVOS) — Market Cap & Net Worth
Market Cap & Net Worth: Novo Integrated Sciences Inc (NVOS)
Novo Integrated Sciences Inc (NASDAQ:NVOS) has a market capitalization of $13.81K ($13.81K) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31566 globally and #6236 in its home market, demonstrating a -92.22% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Novo Integrated Sciences Inc's stock price $0.00 by its total outstanding shares 19730247 (19.73 Million). Review Novo Integrated Sciences Inc balance sheet liabilities to assess the company's total debt and financial obligations.
Novo Integrated Sciences Inc Market Cap History: 2025 to 2026
Novo Integrated Sciences Inc's market capitalization history from 2025 to 2026. Data shows growth from $53.27K to $13.81K (0.00% CAGR).
Novo Integrated Sciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Novo Integrated Sciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NVOS by Market Capitalization
Companies near Novo Integrated Sciences Inc in the global market cap rankings as of June 18, 2026.
Key companies related to Novo Integrated Sciences Inc by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #323 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1002 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1045 globally with a market cap of $25.71 Billion USD ( €21.99 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1331 globally with a market cap of $19.50 Billion USD ( RM77.67 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #323 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $388.16 |
| #1002 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1045 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.71 Billion | €39.04 |
| #1331 | IHH Healthcare Bhd | KLSE:5225 | $19.50 Billion | RM8.79 |
Novo Integrated Sciences Inc Historical Marketcap From 2025 to 2026
Between 2025 and today, Novo Integrated Sciences Inc's market cap moved from $53.27K to $ 13.81K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $13.81K | -74.07% |
| 2025 | $53.27K | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Novo Integrated Sciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.81K USD |
| MoneyControl | $13.81K USD |
| MarketWatch | $13.81K USD |
| marketcap.company | $13.81K USD |
| Reuters | $13.81K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Novo Integrated Sciences Inc
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, … Read more